Stock Earnings

Question 1

What are Novo Nordisk A/S's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Novo Nordisk A/S has a total asset of $542,902, Net profit of $102,434

Question 2

What are the key financial ratios for NVO?

Accepted Answer

Novo Nordisk A/S's Current ratio is 1.55, has a Net margin is 33.14, sales per share of $69.48.

Question 3

How is Novo Nordisk A/S's revenue broken down by segment or geography?

Accepted Answer

Novo Nordisk A/S largest revenue segment is Victoza, at a revenue of 3,020,000,000 in the most earnings release.For geography, US Revenue is the primary market for Novo Nordisk A/S, at a revenue of 173,166,000,000.

Question 4

Is Novo Nordisk A/S profitable?

Accepted Answer

yes, according to the latest financial statements, Novo Nordisk A/S has a net profit of $102,434

Question 5

Does Novo Nordisk A/S have any liabilities?

Accepted Answer

yes, Novo Nordisk A/S has liability of 348,855

Question 6

How many outstanding shares for Novo Nordisk A/S?

Accepted Answer

Novo Nordisk A/S has a total outstanding shares of 4,439.05

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	327,800	309,064	290,403	232,261	176,954	140,800
Revenue Growth (YoY)	8%	6%	25%	31%	26%	11%
Cost of Revenue	59,496	58,788	43,560	35,765	28,448	23,658
Gross Profit	268,304	250,276	246,843	196,496	148,506	117,142
Selling, General & Admin	67,384	70,279	66,546	60,767	49,932	40,409
Research & Development	52,015	52,039	38,021	29,373	21,761	16,292
Operating Expenses	119,819	122,618	107,942	91,798	72,837	57,784
Other Non Operating Income (Expenses)	--	--	-289	-197	-181	-122
Pretax Income	155,679	130,540	127,191	104,674	69,062	59,080
Income Tax Expense	33,722	28,106	26,203	20,991	13,537	11,323
Net Income	121,957	102,434	100,988	83,683	55,525	47,757
Net Income Growth	17%	1%	21%	51%	16%	13%
Shares Outstanding (Diluted)	4,450.68	4,447.85	4,463	4,494.8	4,544.6	4,606.2
Shares Change (YoY)	0%	0%	-1%	-1%	-1%	-2%
EPS (Diluted)	27.41	23.03	22.63	18.62	12.22	10.37
EPS Growth	17%	2%	22%	52%	18%	15%
Free Cash Flow	31,029	28,989	69,659	70,012	64,134	47,615
Free Cash Flow Per Share	6.97	6.51	15.6	15.57	14.11	10.33
Gross Margin	81.84%	80.97%	85%	84.6%	83.92%	83.19%
Operating Margin	45.29%	41.3%	47.83%	45.07%	42.76%	42.15%
Profit Margin	37.2%	33.14%	34.77%	36.02%	31.37%	33.91%
Free Cash Flow Margin	9.46%	9.37%	23.98%	30.14%	36.24%	33.81%
EBITDA	170,173	149,640	142,247	107,037	78,147	60,989
EBITDA Margin	51.91%	48.41%	48.98%	46.08%	44.16%	43.31%
D&A For EBITDA	21,688	21,982	3,346	2,339	2,478	1,631
EBIT	148,485	127,658	138,901	104,698	75,669	59,358
EBIT Margin	45.29%	41.3%	47.83%	45.07%	42.76%	42.15%
Effective Tax Rate	21.66%	21.53%	20.6%	20.05%	19.6%	19.16%

Novo Nordisk A/S (NVO) Price

NVO Stock Price Chart

NVO Income

Follow-Up Questions